"Simbec Research is a clinical trials organisation, proud to be based in Merthyr Tydfil, South Wales. Thousands of volunteers have taken part in our studies to help advance medicine for all of mankind."

During the past decade, Simbec Research Limited conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 3 clinical trials were completed, i.e. on average, 75% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 2 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Simbec Research Limited" #1 sponsor was "Allergan" with 2 trials, followed by "PharmAthene UK Limited" with 2 trials sponsored, "Accure Therapeutics" with 1 trials sponsored, "Actelion" with 1 trials sponsored and "Diurnal Limited" with 1 trials sponsored. Other sponsors include 0 different institutions and companies that sponsored additional 10 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Simbec Research Limited" #1 collaborator was "Simbec Research" with 4 trials as a collaborator, "MAP Pharmaceuticals, Inc., a wholly owned subsidiary of Allergan" with 2 trials as a collaborator and "National Institute of Allergy and Infectious Diseases (NIAID)" with 2 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Simbec Research Limited" are "Healthy" (3 trials), "Adrenal Insufficiency" (1 trials), "Erectile Dysfunction" (1 trials), "Group B Strep Infection" (1 trials) and "Healthy Subjects" (1 trials). Many other conditions were trialed in "Simbec Research Limited" in a lesser frequency.

Most popular intervention types in "Simbec Research Limited" are "Drug" (9 trials), "Biological" (3 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "IV DHE" (2 trials), "MAP0004" (2 trials), "Alhydrogel" (1 trials), "Catapres 100μg" (1 trials) and "Clonidine MBT 100µg" (1 trials). Other intervention names were less common.

The vast majority of trials in "Simbec Research Limited" are 8 trials for "All" genders, 3 trials for "Male" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Simbec Research Limited". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 12 completed trials in Simbec Research Limited, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Simbec Research Limited, 11 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".